- Refined quantitative fluorescent PCR of Y-chromosome DNA sequences mosaics in Turner's syndrome patients--alternative to real-time PCR. Vodicka, R., Vrtel, R., Scheinost, O., Zapletalova, J., Dusek, L., Marie, G., Santavy, J. J. Biochem. Biophys. Methods (2004)
- Variation in dental and skeletal open bite malocclusion in humans with amelogenesis imperfecta. Ravassipour, D.B., Powell, C.M., Phillips, C.L., Hart, P.S., Hart, T.C., Boyd, C., Wright, J.T. Arch. Oral Biol. (2005)
- Amelogenin dosage compensation in carcinoma of colon, lung, liver and kidney, is not a marker of clonality in males. Zvejnieks, P.A., Tellschow, S.R., Gudlaugsson, E.G., Markham, N., Shroyer, K.R. Mol. Cell. Probes (1998)
- Transgenic Mice that Express Normal and Mutated Amelogenins. Gibson, C.W., Yuan, Z.A., Li, Y., Daly, B., Suggs, C., Aragon, M.A., Alawi, F., Kulkarni, A.B., Wright, J.T. J. Dent. Res. (2007)
- Analysis of amelogenin gene (AMGX, AMGY) expression in ameloblastoma. Tsujigiwa, H., Nagatsuka, H., Han, P.P., Gunduz, M., Siar, C.H., Oida, S., Nagai, N. Oral Oncol. (2005)
- AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties. Gavva, N.R., Tamir, R., Qu, Y., Klionsky, L., Zhang, T.J., Immke, D., Wang, J., Zhu, D., Vanderah, T.W., Porreca, F., Doherty, E.M., Norman, M.H., Wild, K.D., Bannon, A.W., Louis, J.C., Treanor, J.J. J. Pharmacol. Exp. Ther. (2005)
- Validity of a short form of the Achievement-Motive Grid (AMG-S): evidence for the three-factor structure emphasizing active and passive forms of fear of failure. Schmalt, H.D. Journal of personality assessment. (2005)
- Transport of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard (D-19575) into tumor cells is mediated by the Na+-D-glucose cotransporter SAAT1. Veyhl, M., Wagner, K., Volk, C., Gorboulev, V., Baumgarten, K., Weber, W.M., Schaper, M., Bertram, B., Wiessler, M., Koepsell, H. Proc. Natl. Acad. Sci. U.S.A. (1998)
- The human enamel protein gene amelogenin is expressed from both the X and the Y chromosomes. Salido, E.C., Yen, P.H., Koprivnikar, K., Yu, L.C., Shapiro, L.J. Am. J. Hum. Genet. (1992)
- AMG 706, an Oral, Multikinase Inhibitor that Selectively Targets Vascular Endothelial Growth Factor, Platelet-Derived Growth Factor, and Kit Receptors, Potently Inhibits Angiogenesis and Induces Regression in Tumor Xenografts. Polverino, A., Coxon, A., Starnes, C., Diaz, Z., Demelfi, T., Wang, L., Bready, J., Estrada, J., Cattley, R., Kaufman, S., Chen, D., Gan, Y., Kumar, G., Meyer, J., Neervannan, S., Alva, G., Talvenheimo, J., Montestruque, S., Tasker, A., Patel, V., Radinsky, R., Kendall, R. Cancer Res. (2006)
- Triggering of the CD44 antigen on T lymphocytes promotes T cell adhesion through the LFA-1 pathway. Koopman, G., van Kooyk, Y., de Graaff, M., Meyer, C.J., Figdor, C.G., Pals, S.T. J. Immunol. (1990)
- Effects of flavophospholipol on resistance in fecal Escherichia coli and enterococci of fattening pigs. van den Bogaard, A.E., Hazen, M., Hoyer, M., Oostenbach, P., Stobberingh, E.E. Antimicrob. Agents Chemother. (2002)
- Therapy Insight: osteoporosis during hormone therapy for prostate cancer. Smith, M.R. Nature clinical practice. Urology. (2005)
- Genetic heterogeneity in X-linked amelogenesis imperfecta. Aldred, M.J., Crawford, P.J., Roberts, E., Gillespie, C.M., Thomas, N.S., Fenton, I., Sandkuijl, L.A., Harper, P.S. Genomics (1992)
- Amelogenin p.M1T and p.W4S mutations underlying hypoplastic X-linked amelogenesis imperfecta. Kim, J.W., Simmer, J.P., Hu, Y.Y., Lin, B.P., Boyd, C., Wright, J.T., Yamada, C.J., Rayes, S.K., Feigal, R.J., Hu, J.C. J. Dent. Res. (2004)
- Human developing enamel proteins exhibit a sex-linked dimorphism. Fincham, A.G., Bessem, C.C., Lau, E.C., Pavlova, Z., Shuler, C., Slavkin, H.C., Snead, M.L. Calcif. Tissue Int. (1991)
- A nomenclature for X-linked amelogenesis imperfecta. Hart, P.S., Hart, T.C., Simmer, J.P., Wright, J.T. Arch. Oral Biol. (2002)
- Amelogenesis imperfecta phenotype-genotype correlations with two amelogenin gene mutations. Hart, P.S., Aldred, M.J., Crawford, P.J., Wright, N.J., Hart, T.C., Wright, J.T. Arch. Oral Biol. (2002)
- Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital. Leflon-Guibout, V., Jurand, C., Bonacorsi, S., Espinasse, F., Guelfi, M.C., Duportail, F., Heym, B., Bingen, E., Nicolas-Chanoine, M.H. Antimicrob. Agents Chemother. (2004)
- Markers of cell activation and apoptosis in bone marrow mononuclear cells of patients with autoimmune hepatitis type 1 and primary biliary cirrhosis. Tsikrikoni, A., Kyriakou, D.S., Rigopoulou, E.I., Alexandrakis, M.G., Zachou, K., Passam, F., Dalekos, G.N. J. Hepatol. (2005)
- Can spatial and temporal motion integration compensate for deficits in local motion mechanisms? Vaina, L.M., Gryzwacz, N.M., Saiviroonporn, P., LeMay, M., Bienfang, D.C., Cowey, A. Neuropsychologia. (2003)
- Aminoguanidine and metformin prevent the reduced rate of HDL-mediated cell cholesterol efflux induced by formation of advanced glycation end products. Machado, A.P., Pinto, R.S., Moysés, Z.P., Nakandakare, E.R., Quintão, E.C., Passarelli, M. Int. J. Biochem. Cell Biol. (2006)
- MAP kinase p38 inhibitors: clinical results and an intimate look at their interactions with p38alpha protein. Lee, M.R., Dominguez, C. Current medicinal chemistry. (2005)
- Expression of glucose transporters in human peritoneal mesothelial cells. Schröppel, B., Fischereder, M., Wiese, P., Segerer, S., Huber, S., Kretzler, M., Heiss, P., Sitter, T., Schlöndorff, D. Kidney Int. (1998)
- Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes. Zheng, L., Gong, B., Hatala, D.A., Kern, T.S. Invest. Ophthalmol. Vis. Sci. (2007)
- Nance-Horan syndrome: a contiguous gene syndrome involving deletion of the amelogenin gene? A case report and molecular analysis. Franco, E., Hodgson, S., Lench, N., Roberts, G.J. Oral diseases. (1995)
- Relationship of phenotype and genotype in X-linked amelogenesis imperfecta. Wright, J.T., Hart, P.S., Aldred, M.J., Seow, K., Crawford, P.J., Hong, S.P., Gibson, C.W., Hart, T.C. Connect. Tissue Res. (2003)
- Isolation and partial characterization of a human amelogenin from a single fetal dentition using HPLC techniques. Fincham, A.G., Hu, Y.Y., Lau, E., Pavlova, Z., Slavkin, H.C., Snead, M.L. Calcif. Tissue Int. (1990)
- Identification of the enamelin (g.8344delG) mutation in a new kindred and presentation of a standardized ENAM nomenclature. Hart, P.S., Michalec, M.D., Seow, W.K., Hart, T.C., Wright, J.T. Arch. Oral Biol. (2003)
- Molecular biology of hereditary enamel defects. Aldred, M.J., Crawford, P.J. Ciba Found. Symp. (1997)
- Microphthalmia with linear skin defects syndrome (MLS): a male with a mosaic paracentric inversion of Xp. Kutsche, K., Werner, W., Bartsch, O., von der Wense, A., Meinecke, P., Gal, A. Cytogenet. Genome Res. (2002)
- Amelogenin cross-amplification in the family Bovidae and its application for sex determination. Weikard, R., Pitra, C., Kühn, C. Mol. Reprod. Dev. (2006)
- Autosomal localization of the amelogenin gene in monotremes and marsupials: implications for mammalian sex chromosome evolution. Watson, J.M., Spencer, J.A., Graves, J.A., Snead, M.L., Lau, E.C. Genomics (1992)
- A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. Bekker, P.J., Holloway, D.L., Rasmussen, A.S., Murphy, R., Martin, S.W., Leese, P.T., Holmes, G.B., Dunstan, C.R., DePaoli, A.M. J. Bone Miner. Res. (2004)
- Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand. Wang, B., Nichol, J.L., Sullivan, J.T. Clin. Pharmacol. Ther. (2004)